FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
ARIXTRA
fondaparinux sodium
LOE Approaching
Viatris (2)
SUBCUTANEOUS · SOLUTION
deep vein thrombosis (DVT) in adultswhich may lead to pulmonary embolism (PE): • in patients undergoing hip fracture surgery+8
2001
NDA30/100
ARNUITY ELLIPTA
fluticasone furoate
Peak
GSK
INHALATION · POWDER
asthma
2014
NDA30/100
AROMASIN
exemestane
LOE Approaching
Pfizer
ORAL · TABLET
advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy ()breast cancer
1999
NDA30/100
ARRANON
nelarabine
LOE Approaching
Novartis
INTRAVENOUS · INJECTABLE
T-cell lymphoblastic lymphoma (T-LBL) in adultolder whose disease has not responded to+2
2005
NDA30/100
ARTANE
trihexyphenidyl hydrochloride
LOE Approaching
Pfizer
ORAL · ELIXIR
1949
NDA30/100
ARTANE
trihexyphenidyl hydrochloride
LOE Approaching
Pfizer
ORAL · CAPSULE, EXTENDED RELEASE
1962
NDA30/100
ARTHROTEC
diclofenac sodium and misoprostol
LOE Approaching
Pfizer
ORAL · TABLET, DELAYED RELEASE
the signssymptoms of osteoarthritis+6
1997
NDA30/100
ASACOL
mesalamine
LOE Approaching
ORAL · TABLET, DELAYED RELEASE
mildly to moderately active ulcerative colitisfor the maintenance of remission of ulcerative colitis+1
1992
NDA30/100
ASACOL HD
mesalamine
LOE Approaching
AbbVie
ORAL · TABLET, DELAYED RELEASE
ulcerative colitis
2008
NDA30/100
ASCLERA
polidocanol
LOE Approaching
INTRAVENOUS · SOLUTION
2010
NDA30/100
ASCOR
ascorbic acid
Peak
INTRAVENOUS · SOLUTION
vitamin C deficiencysymptoms of scurvy
2017
NDA30/100
ASENDIN
amoxapine
LOE Approaching
Pfizer
ORAL · TABLET
depressionanxiety
1980
NDA30/100
ASMANEX HFA
mometasone furoate
Peak
Merck & Co.
INHALATION · AEROSOL, METERED
asthma
2014
NDA30/100
ASMANEX TWISTHALER
mometasone furoate
LOE Approaching
Merck & Co.
INHALATION · POWDER
children less than 4 years of ageasthma
2005
NDA30/100
ASTAGRAF XL
tacrolimus extended-release capsules
Peak
Astellas
ORAL · CAPSULE, EXTENDED RELEASE
organ rejection in kidney transplant patients in combination with other immunosuppressants in adult
2013
NDA30/100
ASTELIN
azelastine hydrochloride
LOE Approaching
NASAL · SPRAY, METERED
the symptoms of seasonal allergic rhinitis suchsneezing+8
1996
NDA30/100
ASTEPRO
azelastine hydrochrloride
LOE Approaching
Viatris (2)
NASAL · SPRAY, METERED
2009
NDA30/100
ATACAND
candesartan cilexetil
LOE Approaching
ANI Pharmaceuticals
ORAL · TABLET
hypertension in adultschildren 1 to <17 years of age+7
1998
NDA30/100
ATACAND HCT
candesartan cilexetil and hydrochlorothiazide
LOE Approaching
ANI Pharmaceuticals
ORAL · TABLET
hypertensionto lower blood pressure+1
2000
NDA30/100
ATARAX
hydroxyzine hydrochloride
LOE Approaching
Pfizer
ORAL · TABLET
anxiety
1956
NDA30/100
ATARAX
hydroxyzine hydrochloride
LOE Approaching
Pfizer
ORAL · SYRUP
anxiety
1956
NDA30/100
ATIVAN
lorazepam
LOE Approaching
Hikma
INJECTION · INJECTABLE
status epilepticusproducing sedation (sleepiness+4
1980
NDA30/100
ATIVAN
lorazepam
LOE Approaching
Bausch + Lomb
ORAL · TABLET
anxiety disordersfor the short-term relief of the symptoms of anxiety+2
1977
NDA30/100
ATNAA
atropine and pralidoxime chloride
LOE Approaching
Medica Corp
INTRAMUSCULAR · INJECTABLE
poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults
2002
NDA30/100